ACE and hydrops fetalis: Metformin was associated with an 18%-reduced mortality in HF with both preserved and reduced EF, especially in HF patients treated with therapies such as angiotensin-converting enzyme inhibitors (ACEi) and beta blockers (β = −0.2 [95% CI −0.3 to −0.1], p = 0.02).